Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group

Low-coherence Enhanced Backscattering (LEBS) for Colon Cancer Screening

Not Accessible

Your library or personal account may give you access

Abstract

We utilize LEBS to evaluate uninvolved mucosa in animal and human colon carcinogenesis. We demonstrate that LEBS has the potential to diagnose the earliest, histologically undetectable, precancerous alterations and may enable accurate screening without colonoscopy.

© 2005 Optical Society of America

PDF Article
More Like This
Risk stratification of colon cancer using low-coherence enhanced backscattering spectroscopy

Young L. Kim, Yang Liu, Vladimir M. Turzhitsky, Ramesh K. Wali, Hemant K. Roy, and Vadim Backman
SD1 Biomedical Topical Meeting (BIOMED) 2006

Quantifying the Field Effect of Carcinogenesis with Low-Coherence Enhanced Backscattering Spectroscopy (LEBS)

Vladimir Turzhitsky, Young L. Kim, Prabhakar Pradhan, Hemant K. Roy, Randall E. Brand, Jay L. Hoogheem, Michael J. Jung, Mohammed Jameel, Nahla Hasabou, and Vadim Backman
BTuC6 Biomedical Optics (BIOMED) 2008

An Endoscope Compatible Low-coherence Enhanced Backscattering Spectroscopy Probe for Cancer Screening

Jeremy D. Rogers, Vladimir M. Turzhitsky, Nikhil N. Mutyal, Andrew Gomes, Alexey Kromin, and Vadim Backman
BTuF10 Biomedical Optics (BIOMED) 2008

Select as filters


Select Topics Cancel
© Copyright 2024 | Optica Publishing Group. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.